腹部MRI遗传学研究确定调控铁调素的基因是肝脏铁含量的主要决定因素
基于UK Biobank 8,289名个体MRI定量肝脏铁的全基因组关联研究,并在IMI DIRECT 1,513人中验证,鉴定出HFE基因rs1800562(C282Y)和rs1799945(H63D)及TMPRSS6基因rs855791(V736A)共3个独立变异与肝脏铁含量相关(p<5×10-8)。孟德尔随机化提示中心性肥胖较高对肝脏铁含量增加有因果作用,全表型关联分析显示肝脏铁变异与多种疾病共享病因机制。
要点
- HFE基因rs1800562(C282Y)和rs1799945(H63D)及TMPRSS6基因rs855791(V736A)与肝脏铁含量达到GWAS显著性阈值相关。
- 两个HFE变异解释约85%的遗传性血色病病例。
- 孟德尔随机化提供证据表明较高的中心性肥胖对肝脏铁含量增加有因果作用。
核心结论
- 研究提供遗传学证据表明肝脏铁含量较高的机制可能是全身性而非器官特异性。
- 较高的中心性肥胖与较高的肝脏铁含量存在因果关联。
- 肝脏铁与多种代谢及非代谢性疾病共享共同病因。
研究设计与样本
- 在UK Biobank 8,289名经MRI定量肝脏铁含量的个体中进行全基因组关联研究(GWAS)。
- 在IMI DIRECT独立队列(n=1,513)中验证发现。
- 使用孟德尔随机化检验25种主要代谢特征对肝脏铁含量的因果效应。
- 检验肝脏铁变异与770种特征和疾病结局的全表型关联。
主要发现
- 鉴定出3个独立遗传变异与肝脏铁含量相关并达到GWAS显著性阈值(p<5×10-8):HFE基因rs1800562(C282Y)和rs1799945(H63D),TMPRSS6基因rs855791(V736A)。
- 两个HFE变异解释约85%的遗传性血色病病例。
- 孟德尔随机化分析提供证据表明较高的中心性肥胖对肝脏铁含量增加起因果作用。
- 全表型关联分析显示肝脏铁升高与高血压、肝硬化、恶性肿瘤、神经精神及风湿性疾病共享病因机制,同时与贫血、脂质异常和缺血性心脏病呈反向关联。
关键数值与推荐
- GWAS显著性阈值定义为p<5×10-8。
- HFE基因rs1800562(C282Y)和rs1799945(H63D)及TMPRSS6基因rs855791(V736A)与肝脏铁含量相关达到GWAS显著性阈值。
- 两个HFE变异解释约85%的遗传性血色病病例。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Excess liver iron content is common and is linked to the risk of hepatic and extrahepatic diseases. We aimed to identify genetic variants influencing liver iron content and use genetics to understand its link to other traits and diseases. METHODS: First, we performed a genome-wide association study (GWAS) in 8,289 individuals from UK Biobank, whose liver iron level had been quantified by magnetic resonance imaging, before validating our findings in an independent cohort (n = 1,513 from IMI DIRECT). Second, we used Mendelian randomisation to test the causal effects of 25 predominantly metabolic traits on liver iron content. Third, we tested phenome-wide associations between liver iron variants and 770 traits and disease outcomes. RESULTS: We identified 3 independent genetic variants (rs1800562 [C282Y] and rs1799945 [H63D] in HFE and rs855791 [V736A] in TMPRSS6) associated with liver iron content that reached the GWAS significance threshold (p <5 × 10-8). The 2 HFE variants account for ∼85% of all cases of hereditary haemochromatosis. Mendelian randomisation analysis provided evidence that higher central obesity plays a causal role in increased liver iron content. Phenome-wide association analysis demonstrated shared aetiopathogenic mechanisms for elevated liver iron, high blood pressure, cirrhosis, malignancies, neuropsychiatric and rheumatological conditions, while also highlighting inverse associations with anaemias, lipidaemias and ischaemic heart disease. CONCLUSION: Our study provides genetic evidence that mechanisms underlying higher liver iron content are likely systemic rather than organ specific, that higher central obesity is causally associated with higher liver iron, and that liver iron shares common aetiology with multiple metabolic and non-metabolic diseases. LAY SUMMARY: Excess liver iron content is common and is associated with liver diseases and metabolic diseases including diabetes, high blood pressure, and heart disease. We identified 3 genetic variants that are linked to an increased risk of developing higher liver iron content. We show that the same genetic variants are linked to higher risk of many diseases, but they may also be associated with some health advantages. Finally, we use genetic variants associated with waist-to-hip ratio as a tool to show that central obesity is causally associated with increased liver iron content.
引用
- Wilman HR, Parisinos CA, Atabaki-Pasdar N, et al. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration. J Hepatol. 2019. PMID: 31226389. doi:10.1016/j.jhep.2019.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。